Cautions
Contraindications
Warnings/Precautions
General Precautions
Cardiovascular Effects
Rapid IV administration associated rarely with hypotension, cardiac arrhythmias; avoid.
Gastric Malignancy
Response to cimetidine does not preclude presence of gastric malignancy.
CNS Effects
Reversible confusional states reported, especially in geriatric (i.e., ≥50 years) and severely ill (e.g., hepatic or renal disease, organic brain syndrome) patients. Usually occurs within 2–3 days after initiating cimetidine and resolves within 3–4 days after discontinuance.
Respiratory Effects
Administration of H2-receptor antagonists has been associated with an increased risk for developing certain infections (e.g., community-acquired pneumonia).
Specific Populations
Pregnancy
Category B.
Pregnant women should consult a clinician before using for self-medication.
Lactation
Distributed into milk. Generally, do not nurse during therapy with cimetidine.
Nursing women should consult a clinician before using for self-medication.
Pediatric Use
Safety and efficacy not established in children <16 years of age; do not use unless potential benefits outweigh risks.
Safety and efficacy for self-medication not established in children <12 years of age; do not use unless directed by a clinician.
Renal Impairment
Dosage adjustments necessary in patients with severe renal impairment. (See Renal Impairment under Dosage and Administration.)
Hepatic Impairment
Further dosage adjustments may be necessary in presence of severe renal impairment. (See Hepatic Impairment under Dosage and Administration.)
Immunocompromised Patients
Increased possibility of Strongyloides stercoralis hyperinfection with decreased gastric acidity.
Common Adverse Effects
Headache, dizziness, somnolence, diarrhea.
With ≥1 month of therapy: gynecomastia.
With IM therapy: transient pain at injection site.
Drug Interactions
Inhibits hepatic microsomal enzyme systems, decreases hepatic metabolism of some drugs. If necessary, adjust dosage of hepatically metabolized drugs when cimetidine therapy is initiated or discontinued.
Specific Drugs
| Drug |
Interaction |
Comments |
| Alcohol |
Possible increased blood alcohol concentrations, psychomotor impairment |
Potential for psychomotor impairment controversial, but use caution during performance of hazardous tasks requiring mental alertness, physical coordination |
| Antacids |
Decreased cimetidine absorption |
Administer 1 hour before or after cimetidine in the fasting state, or 1 hour after cimetidine is taken with food. |
| Benzodiazepines |
Potential for delayed elimination, increased blood concentrations of certain benzodiazepines (e.g., diazepam, chlordiazepoxide, triazolam) |
Adjust dosage if needed |
| Calcium-channel blockers (e.g., nifedipine) |
Potential for delayed elimination, increased blood concentrations of nifedipine |
Adjust dosage if needed |
| Ketoconazole |
Absorption of ketoconazole may be affected by altered gastric pH |
Administer ≥2 hours before cimetidine |
| Lidocaine |
Potential for delayed elimination, increased blood concentrations of lidocaine |
Adverse effects reported, adjust dosage if needed |
| Metronidazole |
Potential for delayed elimination, increased blood concentrations of metronidazole |
Adjust dosage if needed |
| Myelosuppressive drugs (e.g., alkylating agents [e.g., carmustine], antimetabolites) and/or therapies (radiation) |
May potentiate myelosuppression |
|
| Phenytoin |
Potential for delayed elimination, increased blood concentrations of phenytoin |
Adverse effects reported, adjust dosage if needed |
| Propranolol |
Potential for delayed elimination, increased blood concentrations of propranolol |
Adjust dosage if needed |
| Theophylline |
Potential for delayed elimination, increased blood concentrations of theophylline |
Adverse effects reported, adjust dosage if needed |
| Triamterene |
Potential for delayed elimination, increased blood concentrations of triamterene |
Consider potential of clinically important interaction |
| Tricyclic Antidepressants |
Potential for delayed elimination, increased blood concentrations of certain tricyclic antidepressants |
Adjust dosage if needed |
| Warfarin |
Potential for delayed elimination, increased blood concentrations of warfarin |
Monitor PT, adjust dosage if needed |